IRIS
PISCIOTTA, LIVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.512
AS - Asia 119
SA - Sud America 47
NA - Nord America 5
AF - Africa 1
Totale 13.684
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.507
CN - Cina 77
BR - Brasile 40
VN - Vietnam 21
SG - Singapore 11
HK - Hong Kong 7
AR - Argentina 5
US - Stati Uniti d'America 5
RU - Federazione Russa 4
BH - Bahrain 1
EC - Ecuador 1
EG - Egitto 1
ID - Indonesia 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 13.684
Salva come PNG Salva come JPEG
Città #
Genova 6.691
Genoa 4.640
Vado Ligure 1.105
Rapallo 1.023
Bordighera 41
Beijing 35
Singapore 10
Ho Chi Minh City 7
Hong Kong 7
Ashburn 5
Hanoi 3
São Paulo 3
Brasília 2
Crevalcore 2
Hải Dương 2
Porto Alegre 2
Taboão da Serra 2
Verona 2
Alexandria 1
Alvorada 1
Balashikha 1
Barbacena 1
Barra do Piraí 1
Bauru 1
Belford Roxo 1
Belo Horizonte 1
Biên Hòa 1
Blumenau 1
Bofete 1
Bratislava 1
Buenos Aires 1
Campinas 1
Carapicuíba 1
Carpina 1
Catanduva 1
City Bell 1
Cristópolis 1
Diadema 1
Divinópolis 1
Fighiera 1
Formiga 1
Guarulhos 1
Guayaquil 1
Ipojuca 1
Ipubi 1
Jucás 1
Lahore 1
Magé 1
Manama 1
Manaus 1
Nha Trang 1
Osasco 1
Petrópolis 1
Phú Thọ 1
Phủ Lý 1
Reconquista 1
Rio de Janeiro 1
Safonovo 1
Salvador 1
Santos 1
Sarandi 1
St Petersburg 1
Sumaré 1
São João del Rei 1
Taganrog 1
Thành Phố Bà Rịa 1
Tocantinópolis 1
Villa Dolores 1
Totale 13.632
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 262
Lipoproteins, stroke and statins. 199
Manuale di dietistica e dietetica applicata. Vol. 2 191
A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla) 180
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 171
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 167
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 166
A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. 160
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients. 158
A silent mutation of Niemann-Pick C1-like 1 and apolipoprotein E4 modulate cholesterol absorption in primary hyperlipidemias. 158
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 154
An apparent inconsistency in parent to offspring transmission of point mutations of LDLR gene in familial hypercholesterolemia. 149
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. 149
A “de novo” mutation of the LDL-receptor gene as the cause of familial hypercholesterolemia. 147
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 146
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. 146
Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer 143
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 143
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia. 142
Genetic polymorphisms affecting the phenotypic expression in familial hypercholesterolemia 141
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 141
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. 140
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 140
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison. 140
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 140
Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin. 139
Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations. 138
Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia 137
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene 136
Carotid ultrasonography in the assessment of cardiovascular risk 135
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. 135
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 135
The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia 132
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene 131
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e. 130
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency. 129
Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs 128
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 128
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. 127
Long term substrate reduction therapy with ezetimibe alone or associated with statins in three adult patients with lysosomal acid lipase deficiency 126
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs) 126
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia. 124
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 123
Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia. 123
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 123
Severe HDL deficiency due to novel defects in the ABCA1 transporter. 122
Two Italian Kindreds Carrying the Arg136>Ser Mutation of Apo E Gene: Development of Premature and Severe Atherosclerosis in the presence of Epsilon 2 as Second Allele 122
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 122
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 121
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 120
Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years. 118
Adiponectin/leptin ratio predicts the remission of metabolic syndrome: A pilot study 117
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 117
Molecular characterization of two patients with severe LCAT deficiency. 114
Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients 114
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency. 113
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders 112
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 111
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 110
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. 108
Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants 106
Changes in the Expression of the Nuclear Matrix Intermediate Filament Complex Proteins are correlated with the Level of Differentiation in Human Prostate Cancer. 106
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 105
Pharmacological treatment of a Sardinian patient affected by autosomal recessive hypercholesterolemia (ARH) 104
Denaturing high-performance liquid chromatography (DHPLC) in the detection of mutations of ABCA1 gene in Familial HDL Deficiency. 103
Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene. 103
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. 99
Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia : a study of patients with familial hypercholesterolemia from Sardinia. 97
Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies 97
PCSK9 inhibitors for treating hypercholesterolemia 97
First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias 96
Beta-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia. 95
Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia - Brief Report 94
Clinical Expression of Familial Hypercholesterolemia in clusters of mutations of LDL-receptor gene causing receptor-defective or receptor-negative phenotype 92
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. 92
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 91
Troponin elevation does not always mean cardiac ischemia. 90
The study of familial hypercholesterolemia in Italy: A narrative review 89
Among biomarkers of neutrophil activity, matrix metalloproteinases 8 independently predicts remission of metabolic syndrome 86
Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study 85
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity 83
Le ipercolesterolemie familiari: forme dominanti e recessive (FH, FDB, FH3, FH4, ARH, beta-sitosterolemia, Deficit di 7alpha-idrossilasi). 83
Evaluation of RNA messangers involved in lipid trafficking of human intestinal cells by RT-PCR with competimer technology and microchip electrophoresis. 83
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 82
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 81
Diet and nutraceutical supplementation in dyslipidemic patients: First results of an italian single center real‐world retrospective analysis 80
A successful term pregnancy with severe hypertriglyceridaemia and acute pancreatitis. Clinical management and review of the literature 79
Lipoprotein Glomerulopathy: molecular chatacterization of three Italian patients and literature survey. 78
Two novel rare variants of APOA5 gene found in subjects with severe hypertrigliceridemia. 77
Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis 77
Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity 76
Effects of a mediterranean diet, dairy, and meat products on different phenotypes of dyslipidemia: A preliminary retrospective analysis 76
Characterization of Three Kindred with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 75
Evaluation of the efficacy of plant sterols supplement sterolip® ESI in patients with type IIA hypercholesterolemia in relation to Genetic variants modulating intestinal absorption of cholesterol 71
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 70
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 69
LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters 69
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 69
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study 69
Effect of statin treatment on arterial stiffness in individuals with newly-diagnosed Heterozygous Familial Hypercholesterolemia. 67
Totale 11.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.618
article - articoli 49.663
book - libri 379
conference - conferenze 15
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 561
Totale 101.236
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021682 0 0 0 67 104 72 35 94 68 104 79 59
2021/20221.299 41 109 100 131 47 101 87 296 77 99 73 138
2022/20231.241 121 82 15 111 179 229 53 87 181 51 116 16
2023/2024989 37 90 22 104 109 188 60 65 36 57 87 134
2024/20252.904 110 187 126 224 295 282 252 469 134 137 302 386
2025/20262.046 644 234 519 649 0 0 0 0 0 0 0 0
Totale 14.073